期刊
CELL STEM CELL
卷 16, 期 6, 页码 576-577出版社
CELL PRESS
DOI: 10.1016/j.stem.2015.05.010
关键词
-
资金
- Wellcome Trust [97922] Funding Source: Medline
Stimulating an endogenous regenerative response is a powerful approach for potential treatment of chronic demyelinating diseases such as multiple sclerosis. Recently in Nature, Najm et al. (2015) identified two clinically relevant, FDA-approved compounds that promote oligodendrocyte progenitor cell differentiation and induce remyelination in demyelinating disease models.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据